ICYMI: State of Georgia Bio Virtual Town Hall Recording

As many of our colleagues are now aware, Georgia Bio (and the Georgia BioEd Institute) is separating from the Center for Global Health Innovation (CGHI) and adopting a more incremental, industry-focused approach to our efforts. Georgia Bio is recommitting to its core mission of advocating for, connecting, educating and inspiring our member enterprises and stakeholders in much the same way our colleagues have known Georgia Bio since its inception in 1989. To achieve this, the organization transitioned from a 501c3 to an independent 501c6 organization, Georgia Biosciences Organization, Inc. Our new EIN# is 27-3855537.

What About My Membership?

CGHI members will receive complimentary membership with Georgia Biosciences Org. until their next scheduled renewal date when they will be invited to renew with Georgia Biosciences Org. We are happy to work to establish the organization as a new vendor with your company/organization as needed.

On Wednesday, October 18, Georgia Bio CEO Maria Thacker led a virtual ‘town hall’ to discuss the state of Georgia Bio, Georgia BioEd and the larger life science ecosystem in the state. If you weren’t able to join us, or would like to share the conversation with colleagues, the recording is here.

The 2023 Georgia Life Sciences Summit – November 1

T he 2023 edition of the Georgia Life Science Innovation Summit is right around the corner. The summit, more concentrated in scope yet expansive in industry inclusion, will be Wednesday, November 1st at the Sandy Springs Arts Center. The program is coming along nicely including a recently secured keynote or plenary address featuring Dr. Ted W. Love, former President and CEO of Global Blood Therapeutics and 2023-2025 Chair of the Board of the Biotechnology Innovation Organization (BIO).

We encourage you to join us in reconnecting with the life science industry ecosystem. Learn more and register here.

The post ICYMI: State of Georgia Bio Virtual Town Hall Recording appeared first on Georgia Bio.

< Older Post

Newer Post >

September GBG Report Now Available – Federal Funding Insights for Georgia Life Sciences Members

September 11, 2025

Members are invited to join G2G’s Monthly GBG Reporting Service Webinar on September 18, 2025 . The first portion ( 12:00–12:30 PM ET ) is free and open to all, offering a high-level overview of current federal funding trends. The second half ( 12:30–1:00 PM ET ) is a premium consultation available only to Georgia Life Sciences members, offering direct access to G2G’s expert team—who have helped secure over $550 million in non-dilutive government funding since 2007. Register here: https://www.g2gconsulting.com/event/non-dilutive-funding-g2gs-monthly-gbg-reporting-service-webinar-14-3/2025-09-18/ Key opportunities this month include DARPA’s Expedited Research Innovation System for CBRN threat defense technologies, BARDA’s I-CREATE diagnostic funding and VANGUARD biomanufacturing tools development (each offering up to $200,000), NIAID tuberculosis and influenza research units (up to $1.5–$2.5 million annually), DoD’s $4 million Advanced Medical Monitor development through MTEC, and multiple SBIR opportunities for sensors and field-deployable diagnostics (up to $209,575 for Phase I awards). The September GBG report highlights 13 immunology and infectious disease opportunities, 10 cognitive and brain health programs, and several biotechnology and biomanufacturing initiatives across federal agencies including the Army, ARPA-H, BARDA, and NSF. Georgia Life Sciences members can access the complete 29-page report with detailed deadlines and eligibility requirements [insert link or portal instructions here]. GLS members can access the full 29-page report with deadlines and submission details by logging into your member portal.